Chosen Diagnostics is to improve health care delivery for patients by personalizing their medicine.
A biomarker test to diagnose a common and life-threatening bowel disease in preterm infants. It offers more accurate results than current options and allows earlier medical intervention.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 19, 2021 | Grant | $2.10M | 1 | National Institutes of Health | — | Detail |
May 28, 2020 | Grant | $224.75K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |
National Science Foundation | Yes | Grant |